Health outcomes and cost-effectiveness of certolizumab pegol in the treatment of Crohn's disease

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'Health outcomes and cost-effectiveness of certolizumab pegol in the treatment of Crohn's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences